Most Clicked StoriesMore >


EU delays clinical trial disclosures until Oct. 2

DIA Global SmartBrief | Jul 15, 2014

A statement was issued last week by the European Medicines Agency postponing the formal adoption of its policy on disclosing clinical trial data until Oct. 2, saying board members still have to agree on final wording. The agency stressed that its board members "have confirmed their general support to the overall aims and objectives of the policy." PharmaTimes (U.K.) (07/10) Wall Street Journal (tiered subscription model), The (07/09)


Push for reduced taxes helps drive international pharma deals

DIA Global SmartBrief | Jul 17, 2014

Diabetes drug might lower dementia risk

DIA Global SmartBrief | Jul 17, 2014

Global antibiotics use rises 36%, study finds

DIA Global SmartBrief | Jul 15, 2014

Novartis, Google team up on glucose-monitoring contact lens

DIA Global SmartBrief | Jul 17, 2014

U.K.'s Cameron signals renewed focus on life sciences

DIA Global SmartBrief | Jul 17, 2014

Study: Changes in pills' color, shape may result in Rx nonadherence

DIA Global SmartBrief | Jul 17, 2014

List of recognized medtech standards updated by FDA

DIA Global SmartBrief | Jul 15, 2014

India expands price controls of diabetic, heart medicines

DIA Global SmartBrief | Jul 15, 2014

Sovaldi prompts debate over what drug prices health care system can bear

DIA Global SmartBrief | Jul 17, 2014


Find DIA Global SmartBrief Issues by Date:



DIA News More >


Learn the essentials of statistics in clinical trials

DIA Global SmartBrief | Jul 22, 2014

Get the latest updates in diagnosing and managing adverse drug reactions

DIA Global SmartBrief | Jul 22, 2014

Special discount for webinar series on clinical pharmacology in drug development

DIA Global SmartBrief | Jul 17, 2014

Award-winning instructor to lead Clinical Project Management Training

DIA Global SmartBrief | Jul 17, 2014

Registration open for Conference on Cardiac Toxicity

DIA Global SmartBrief | Jul 15, 2014




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more